Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
Clinical Endocrinology|September 21, 2006
Impairment of GH responsiveness to combined GH-releasing hormone and arginine administration in adult patients with Prader-Willi syndromeG Grugni, P Marzullo, L Ragusa, et al.
Hepato-Gastroenterology|August 1, 1992
Management of postoperative bile leakage with endoscopic sphincterotomy (EST) and a naso-biliary drain (NBD)A Foco, A Garbarini, A Franchello, et al.
Human Reproduction (Oxford, England)|August 1, 1997
Ovarian sensitivity to follicle stimulating hormone is blunted in normo-ovulatory women with Down's syndromeR M Cento, L Ragusa, C Proto, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|June 16, 1999
Serum leptin concentrations in obese women with Down syndrome and Prader-Willi syndromeR M Cento, C Proto, R S Spada, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|April 1, 1996
Basal body temperature curves and endocrine pattern of menstrual cycles in Down syndromeR M Cento, L Ragusa, C Proto, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|April 1, 1997
Bilateral non-communicating paraurethral meatus in Prader-Willi syndromeR M Cento, A Alberti, G Brancati, et al.
Journal of Endocrinological Investigation|August 12, 1998
Growth hormone administration normalizes the ovarian responsiveness to follicle-stimulating-hormone in the early stages of the follicular maturation in women with Down syndromeR M Cento, L Ragusa, C Proto, et al.
Il Giornale Di Chirurgia|July 1, 2014
Sentinel lymph node biopsy in head and neck melanoma*G Giudice, S Leuzzi, F Robusto, et al.
European Journal of Pediatrics|September 7, 2007
Pituitary height and neuroradiological alterations in patients with Prader-Labhart-Willi syndromeL Iughetti, L Bosio, A Corrias, et al.
Dementia (Basel, Switzerland)|September 1, 1996
The enhancing effect of pyridostigmine on the GH response to GHRH undergoes an accelerated age-related reduction in Down syndromeE Arvat, L Gianotti, L Ragusa, et al.
Pageof 5